WP's experience at big pharma and rolling out billion dollar drugs gives me a lot reassurance we're heading in the right direction.
Only disappointment is the slow EFS recruitment. May start, we're now in September. That's a big delay for a very small study. Hope these delays don't carry over into the pivotal study.
Eureka report, page-10
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.23 |
Change
-0.120(0.65%) |
Mkt cap ! $341.1M | |||
| Open | High | Low | Value | Volume |
| $18.36 | $18.47 | $17.55 | $151.6K | 8.46K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4 | $17.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.23 | 49 | 5 |
View Market Depth
| Last trade - 14.21pm 03/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |